Control of associated medical conditions (hypertension, diabetes mellitus), vascular endothelial growth factor (VEGF) inhibitors, panretinal photocoagulation, medical treatment for elevated IOP, conventional glaucoma filtering surgery with antifibrotics, glaucoma valve implant surgery, and cyclodestructive procedures are among the main treatment modalities. The gene discussed is VEGFA; the disease is hypertensive disorder.